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Summary 
Nanoscale science, engineering, and technology—commonly referred to collectively as 
nanotechnology—is believed by many to offer extraordinary economic and societal benefits. 
Congress has demonstrated continuing support for nanotechnology and has directed its attention 
primarily to three topics that may affect the realization of this hoped for potential: federal 
research and development (R&D) in nanotechnology; U.S. competitiveness; and environmental, 
health, and safety (EHS) concerns. This report provides an overview of these topics—which are 
discussed in more detail in other CRS reports—and two others: nanomanufacturing and public 
understanding of and attitudes toward nanotechnology. 
The development of this emerging field has been fostered by significant and sustained public 
investments in nanotechnology R&D. Nanotechnology R&D is directed toward the understanding 
and control of matter at dimensions of roughly 1 to 100 nanometers. At this size, the properties of 
matter can differ in fundamental and potentially useful ways from the properties of individual 
atoms and molecules and of bulk matter. Since the launch of the National Nanotechnology 
Initiative (NNI) in 2000 through FY2013, Congress has appropriated approximately $18 billion 
for nanotechnology R&D. President Obama has requested $1.7 billion in NNI funding for 
FY2014. More than 60 nations have established similar programs. In 2010, total annual global 
public R&D investments reached an estimated $8.2 billion, complemented by an estimated 
private sector investment of $9.6 billion. Data on economic outputs used to assess 
competitiveness in mature technologies and industries, such as revenues and market share, are not 
available for assessing nanotechnology. Alternatively, data on inputs (e.g., R&D expenditures) 
and non-financial outputs (e.g., scientific papers, patents) may provide insight into the current 
U.S. position and serve as bellwethers of future competitiveness. By these criteria, the United 
States appears to be the overall global leader in nanotechnology, though some believe the U.S. 
lead may not be as large as it was for previous emerging technologies. 
Some research has raised concerns about the safety of nanoscale materials. There is general 
agreement that more information on EHS implications is needed to protect the public and the 
environment; to assess and manage risks; and to create a regulatory environment that fosters 
prudent investment in nanotechnology-related innovation. Nanomanufacturing—the bridge 
between nanoscience and nanotechnology products—may require the development of new 
technologies, tools, instruments, measurement science, and standards to enable safe, effective, 
and affordable commercial-scale production of nanotechnology products. Public understanding 
and attitudes may also affect the environment for R&D, regulation, and market acceptance of 
products incorporating nanotechnology. 
In 2003, Congress enacted the 21st Century Nanotechnology Research and Development Act (P.L. 
108-153) providing a legislative foundation for some of the activities of the NNI, addressing 
concerns, establishing programs, assigning agency responsibilities, and setting authorization 
levels. Efforts to reauthorize the act have been unsuccessful. As of the date of this report, no 
reauthorization legislation had been introduced in the 113th Congress. In October 2013, the 
ranking member of the House Committee on Science, Space, and Technology circulated a draft 
reauthorization of the America COMPETES Act that included a “Reauthorization of the National 
Nanotechnology Initiative” subtitle. The majority version of the 2013 America COMPETES Act 
reauthorization bill does not include a nanotechnology reauthorization provision. 
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Overview 
Congress continues to demonstrate interest in and support for nanotechnology due to what many 
believe is its extraordinary potential for delivering economic growth, high-wage jobs, and other 
societal benefits to the nation. To date, the Science and Technology Committee in the House and 
Senate Committee on Commerce, Science, and Transportation have directed their attention 
primarily to three topics that may affect the United States’ realization of this hoped for potential: 
federal research and development (R&D) investments under the National Nanotechnology 
Initiative (NNI); U.S. international competitiveness; and environmental, health, and safety (EHS) 
concerns. This report provides a brief overview of these topics—which are discussed in greater 
detail in other CRS reports1—and two other subjects of interest to Congress: nanomanufacturing 
and public attitudes toward, and understanding of, nanotechnology. 
Nanotechnology research and development is directed toward the understanding and control of 
matter at dimensions of roughly 1 to 100 nanometers. At this size, the physical, chemical, and 
biological properties of materials can differ in fundamental and potentially useful ways from the 
properties of individual atoms and molecules, on the one hand, or bulk matter, on the other hand. 
In 2000, President Clinton launched the NNI to coordinate federal R&D efforts and promote U.S. 
competitiveness in nanotechnology. Congress first funded the NNI in FY2001 and has provided 
increased appropriations for nanotechnology R&D in each subsequent year. In 2003, Congress 
enacted the 21st Century Nanotechnology Research and Development Act (P.L. 108-153). The act 
provided a statutory foundation for the NNI, established programs, assigned agency 
responsibilities, authorized agency funding levels for FY2005 through FY2008, and initiated 
research to address key issues.  
Federal R&D investments are focused on advancing understanding of fundamental nanoscale 
phenomena and on developing nanomaterials, nanoscale devices and systems, instrumentation, 
standards, measurement science, and the tools and processes needed for nanomanufacturing. NNI 
appropriations also fund the construction and operation of major research facilities and the 
acquisition of instrumentation. Finally, the NNI supports research directed at identifying and 
managing potential environmental, health, and safety impacts of nanotechnology, as well as its 
ethical, legal, and societal implications. 
Most current applications of nanotechnology are evolutionary in nature, offering incremental 
improvements in existing products and generally modest economic and societal benefits. For 
example, nanotechnology is being used in automobile bumpers, cargo beds, and step-assists to 
reduce weight, increase resistance to dents and scratches, and eliminate rust; in clothes to increase 
stain- and wrinkle-resistance; and in sporting goods, such as baseball bats and golf clubs, to 
improve performance. 
In the longer term, nanotechnology may deliver revolutionary advances with profound economic 
and societal implications. Potential applications discussed by the technology’s proponents involve 
                                                 
1 For additional information on these issues, see CRS Report RL34401, The National Nanotechnology Initiative: 
Overview, Reauthorization, and Appropriations Issues, CRS Report RL34493, Nanotechnology and U.S. 
Competitiveness: Issues and Options, and CRS Report RL34614, Nanotechnology and Environmental, Health, and 
Safety: Issues for Consideration, all by John F. Sargent, and CRS Report RL34332, Engineered Nanoscale Materials 
and Derivative Products: Regulatory Challenges, by Linda-Jo Schierow. 
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various degrees of speculation and varying time-frames. The examples below suggest areas where 
such possible revolutionary advances may emerge, and early research and development efforts 
that may provide insights into how such advances may be achieved. 
• Detection and treatment technologies for cancer and other deadly diseases. 
Current nanotechnology disease detection efforts include the development of 
sensors that can identify biomarkers, such as altered genes, that may provide an 
early indicator of cancer. One approach uses carbon nanotubes and nanowires to 
identify the unique molecular signals of cancer biomarkers. Another approach 
uses nanoscale cantilevers—resembling a row of diving boards—treated with 
molecules that bind only with cancer biomarkers. When these molecules bind, the 
additional weight bends the cantilevers indicating the presence and concentration 
of these biomarkers. Nanotechnology holds promise for showing the presence, 
location, and/or contours of cancer, cardiovascular disease, or neurological 
disease. Current R&D efforts employ metallic, magnetic, and polymeric 
nanoparticles with strong imaging characteristics attached to an antibody or other 
agent that binds selectively with targeted cells. The imaging results can be used 
to guide surgical procedures and to monitor the effectiveness of non-surgical 
therapies in killing the disease or slowing its growth. Nanotechnology may also 
offer new cancer treatment approaches. For example, nanoshells with a core of 
silica and an outer metallic shell can be engineered to concentrate at cancer 
lesion sites. Once at the sites, a harmless energy source (such as near-infrared 
light) can be used to cause the nanoshells to heat, killing the cancer cells they are 
attached to.2 Another treatment approach targets delivery of tiny amounts of a 
chemotherapy drug to cancer cells. In this approach the drug is encapsulated 
inside a nanoshell that is engineered to bind with an antigen on the cancer cell. 
Once bound, the nanoshell dissolves, releasing the chemotherapy drug, killing 
the cancer cell. Such a targeted delivery approach could reduce the amount of 
chemotherapy drug needed to kill the cancer cells, reducing the side effects of 
chemotherapy.3 
• Clean, inexpensive, renewable power through energy creation, storage, and 
transmission technologies. Nanoscale semiconductor catalysts and additives 
show promise for improving the production of hydrogen from water using 
sunlight. The optical properties of these nanoscale catalysts allow the process to 
use a wider spectrum of sunlight. Similarly, nanostructured photovoltaic devices 
(e.g., solar panels) may improve the efficiency of converting sunlight into 
electricity by using a wider spectrum of sunlight. Improved hydrogen storage, a 
key challenge in fuel cell applications, may be achieved by tapping the chemical 
properties and large surface area of certain nanostructured materials. In addition, 
carbon nanotube fibers have the potential for reducing energy transmission losses 
from approximately 7% (using copper wires) to 6% (using carbon nanotube 
                                                 
2 National Cancer Institute website, Nanoshells, http://nano.cancer.gov/learn/understanding/nanotech_nanoshells.asp. 
3 National Cancer Institute website, http://nano.cancer.gov/resource_center/tech_backgrounder.asp Nanotech News, 
Nanoparticles Enhance Combination Chemotherapy and Radiation Therapy, April 2012, http://nano.cancer.gov/action/
news/2012/apr/nanotech_news_2012-4-2f.asp; Nanotech News, First-Of-Its-Kind Self-Assembled Nanoparticle for 
Targeted and Triggered Thermo-Chemotherapy, December 2012, http://nano.cancer.gov/action/news/2012/dec/
nanotech_news_2012-12-13b.asp; and National Cancer Institute, NCI Alliance for Nanotechnology in Cancer, 2011 
NCI Alliance Annual Bulletin, Joe Alper, Nanoparticles Deliver Drug Cocktails to Tumor, 2011. 
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fibers), an equivalent annual energy savings in the United States of 24 million 
barrels of oil.4 
• Universal access to clean water. Nanotechnology water desalination and 
filtration systems may offer affordable, scalable, and portable water filtration 
systems. Filters employing nanoscale pores work by allowing water molecules to 
pass through, but prevent larger molecules, such as salt ions and other impurities 
(e.g., bacteria, viruses, heavy metals, and organic material), from doing so. Some 
nanoscale filtration systems also employ a matrix of polymers and nanoparticles 
that serve to attract water molecules to the filter and to repel contaminants.5 
• High-density memory devices. A variety of nanotechnology applications may 
hold the potential for improving the density of memory storage and accelerate 
access speed to stored data.6 
• Higher crop yield and improved nutrition. Higher crop yield might be 
achieved using nanoscale sensors that detect the presence of a virus or disease-
infecting particle. Early, location-specific detection may allow for rapid and 
targeted treatment of affected areas, increasing yield by preventing losses.7 
Nanotechnology also offers the potential for improved nutrition. Some 
companies are exploring the development of nanocapsules that release nutrients 
targeted at specific parts of the body at specific times.8 
• Self-healing materials. Nanotechnology may offer approaches that enable 
materials to “self-heal” by incorporating, for example, nanocontainers of a repair 
substance (e.g., an epoxy) throughout the material. When a crack or corrosion 
reaches a nanocontainer, the nanocontainer could be designed to open and release 
its repair material to fill the gap and seal the crack.9 
• Sensors that can warn of minute levels of toxins and pathogens in air, soil, or 
water. Microfluidic and nanocantilever sensors (discussed earlier) may be 
engineered to detect specific pathogens (e.g., bacteria, virus) or toxins (e.g., sarin 
                                                 
4 Nanoscience Research for Energy Needs, Nanoscale Science, Engineering, and Technology Subcommittee, National 
Science and Technology Council, The White House, December 2004. 
5 Abraham, M. “Today’s Seawater is Tomorrow’s Drinking Water,” University of California at Los Angeles, 
November 6, 2006; and NNI website, Benefits and Applications, http://www.nano.gov/you/nanotechnology-benefits. 
6 Hewlett-Packard Development Company, L.P. Nanotechnology, http://www.hpl.hp.com/research/about/
nanotechnology.html; and IBM Research, Silicon Integrated Nanophotonics, http://researcher.ibm.com/researcher/
view_project.php?id=2757. 
7 Nanoscale Science and Engineering for Agriculture and Food Systems, draft report on the National Planning 
Workshop, submitted to the Cooperative State Research, Education, and Extension Service of the U.S. Department of 
Agriculture, July 2003. 
8 Kole, Chittaranjan, Kole, Phullara, et al., “Nanobiotechnology Can Boost Crop Production and Quality: First 
Evidence from Increased Plant Biomass, Fruit Yield and Phytomedicine Content in Bitter Melon,” BMC 
Biotechnology, PubMed, April 26, 2013, http://www.ncbi.nlm.nih.gov/pubmed/23622112?dopt=Abstract&holding=
f1000,f1000m,isrctn; and Wolfe, Josh. “Safer and Guilt-Free Nano Foods,” Forbes.com, August 10, 2005. 
9 White, Scott R. and Geubelle, Philippe H., “Self-Healing Materials: Get Ready for Repair-and-Go,” Nature 
Nanotechnology, Vol. 5, pp. 247-248, 2010, http://www.nature.com/nnano/journal/v5/n4/abs/nnano.2010.66.html; 
Berger, Michael. “Nanomaterial Heal Thyself,” Nanowerk Spotlight, June 13, 2007, http://www.nanowerk.com/
spotlight/spotid=2067.php. 
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gas, hydrogen cyanide) by detecting their unique molecular signals or through 
selective binding with an engineered nanoparticle.10 
• Environmental remediation of contaminated sites. The high surface-to-
volume ratio, high reactivity, and small size of some nanoscale particles (e.g., 
nanoscale iron) may offer more effective and less costly solutions to 
environmental contamination. By injecting engineered nanoparticles into the 
ground, these characteristics can be employed to enable the particles to move 
more easily through a contaminated site and bond more readily with targeted 
contaminants.11 
Nanotechnology is also expected by some to make substantial contributions to federal missions 
such as national defense, homeland security, and space exploration and commercialization. 
U.S. private sector nanotechnology R&D is now estimated to be twice that of public funding. In 
general, the private sector’s efforts are focused on translating fundamental knowledge and 
prototypes into commercial products; developing new applications incorporating nanoscale 
materials; and developing technologies, methods, and systems for commercial-scale 
manufacturing. 
Many other nations and firms around the world are also making substantial investments in 
nanotechnology to reap its potential benefits. Between 2001 and 2004, more than 60 countries 
established nanotechnology programs at the national level.12 
With so much potentially at stake, some Members of Congress have expressed interest and 
concerns about the U.S. competitive position in nanotechnology R&D and success in translating 
R&D results to commercial products. This has led to an increased focus on potential barriers to 
commercialization efforts, including the readiness of technologies, systems, and processes for 
large-scale nanotechnology manufacturing; potential environmental, health, and safety (EHS) 
effects of nanoscale materials; public understanding and attitudes toward nanotechnology; and 
other related issues.  
This report provides an overview of the NNI, macro-level view of federal R&D investments in 
nanotechnology, U.S. competitiveness in nanotechnology, and EHS-related issues. 
 
 
                                                 
10 “Nanotechnology for Sensors and Sensors for Nanotechnology,” Nanotechnology Signature Initiative, National 
Science and Technology Council, July 9, 2012, http://www.nano.gov/sites/default/files/pub_resource/
sensors_nsi_2012_07_09_final_for_web.pdf. 
11 EPA website. http://epa.gov/ncer/nano/research/nano_remediation.html. 
12 Mihail C. Roco, “The Long View of Nanotechnology Development: The National Nanotechnology Initiative at 10 
Years,” Journal of Nanoparticle Research, February 2011, p. 428. 
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The National Nanotechnology Initiative 
President Clinton launched the National Nanotechnology Initiative in 2000, establishing a multi-
agency program to coordinate and expand federal efforts to advance the state of nanoscale 
science, engineering, and technology, and to position the United States to lead the world in its 
development and commercialization. The NNI is comprised of 15 federal agencies that receive 
appropriations to conduct and fund nanotechnology R&D and 12 other federal agencies with 
responsibilities for health, safety, and environmental regulation; trade; education; training; 
intellectual property; international relations; and other areas that might affect nanotechnology. 
The Environmental Protection Agency and the Food and Drug Administration both conduct 
nanotechnology R&D and have regulatory responsibilities. 
Congress has played a central role in the NNI, providing appropriations for the conduct of 
nanotechnology R&D (discussed below), establishing programs, and creating a legislative 
foundation for some of the activities of the NNI through enactment of the 21st Century 
Nanotechnology Research and Development Act of 2003. The act authorized appropriations for 
FY2005 through FY2008 for five NNI agencies–the National Science Foundation (NSF), 
Department of Energy (DOE), National Aeronautics and Space Administration (NASA), 
Department of Commerce (DOC) National Institute of Standards and Technology (NIST), and 
Environmental Protection Agency (EPA). Congress remains actively engaged in the NNI.  
While many provisions of the 21st Century Nanotechnology Research and Development Act have 
no sunset provision, FY2008 was the last year of agency authorizations included in the act. 
Legislation to amend and reauthorize the act was introduced in the House (H.R. 5940, 110th 
Congress) and the Senate (S. 3274, 110th Congress) in the 110th Congress. The House passed H.R. 
5940 by a vote of 407-6; the Senate did not act on S. 3274. In January 2009, H.R. 554 (111th 
Congress), the National Nanotechnology Initiative Amendments Act of 2009, was introduced in 
the 111th Congress. The act contained essentially the same provisions as H.R. 5940. In February 
2009, the House passed the bill by voice vote under a suspension of the rules. The bill was 
referred to the Senate Committee on Commerce, Science, and Transportation; no further action 
was taken. On May 7, 2010, the House Committee on Science and Technology reported the 
America COMPETES Reauthorization Act of 2010 (H.R. 5116, 111th Congress) which included, 
as Title I, Subtitle A, of the National Nanotechnology Initiative Amendments Act of 2010. This 
title was removed prior to enactment.13 No reauthorization bill was introduced in the 112th 
Congress.  
In October 2013, the ranking member of the House Committee on Science, Space, and 
Technology circulated a draft reauthorization of the America COMPETES Act that included a 
“Reauthorization of the National Nanotechnology Initiative” subtitle.14 For a a detailed discussion 
of the provisions of this draft, see CRS Report RL34401, The National Nanotechnology 
Initiative: Overview, Reauthorization, and Appropriations Issues, by John F. Sargent Jr. The 
majority version of the America COMPETES Act reauthorization does not include a 
nanotechnology reauthorization provision. 
                                                 
13 For additional information on the reauthorization efforts, see CRS Report RL34401, The National Nanotechnology 
Initiative: Overview, Reauthorization, and Appropriations Issues, by John F. Sargent Jr. 
14 “Ranking Member Johnson Circulates America Competes Discussion Draft,” House Democrats, Committee on 
Science, Space, and Technology, October 29, 2013, http://democrats.science.house.gov/press-release/ranking-member-
johnson-circulates-america-competes-discussion-draft. 
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Structure 
The NNI is coordinated within the White House through the National Science and Technology 
Council’s NSET subcommittee. The NSET subcommittee is comprised of representatives from 27 
federal agencies, White House Office of Science and Technology Policy (OSTP), and Office of 
Management and Budget.15 The NSET subcommittee has established four working groups: the 
National Environmental and Health Implications (NEHI), National Innovation and Liaison with 
Industry (NILI), Global Issues in Nanotechnology (GIN), Nanomanufacturing, and 
Nanotechnology Public Engagement and Communications (NPEC) working groups. The National 
Nanotechnology Coordination Office (NNCO) provides administrative and technical support to 
the NSET subcommittee. 
Funding 
Funding for the NNI is provided through appropriations to each of the NNI-participating 
agencies. The NNI has no centralized funding. Overall NNI funding is calculated by aggregating 
the nanotechnology-related expenditures of each NNI agency. Funding remains concentrated in 
the original six NNI agencies,16 which account for approximately 96% of NNI funding in 
FY2012. The NNI funds fundamental and applied nanotechnology R&D, multidisciplinary 
centers of excellence, and key research infrastructure. It also supports efforts to address societal 
implications of nanotechnology, including ethical, legal, EHS, and workforce issues. 
For FY2012, Congress appropriated an estimated $1.857 billion for nanotechnology R&D, four 
times the $464 million appropriated for nanotechnology R&D in 2001. The NNCO was not able 
to specify FY2013 actual NNI funding in its FY2014 budget supplement due to the late resolution 
of the federal budget process. FY2013 funding remained unavailable at the time of this report. In 
total, Congress has appropriated approximately $18 billion for the NNI from FY2001 to FY2013. 
President Obama has requested $1.702 billion for nanotechnology R&D in FY2014, a $155 
million (8.4%) decrease below the actual FY2012 funding level of $1.857 billion. The chronology 
of NNI funding is detailed in Table 1. 
 
                                                 
15 NSET subcommittee members include Bureau of Industry and Security, DOC; Consumer Product Safety 
Commission; Cooperative State Research, Education, and Extension Service, Department of Agriculture (USDA); 
Department of Defense (DOD); Department of Education; DOE; Department of Homeland Security; Department of 
Justice; Department of Labor; Department of State; Department of Transportation; Department of the Treasury; EPA; 
Food and Drug Administration; Forest Service, USDA; Intelligence Technology Innovation Center; International Trade 
Commission; NASA; National Institutes of Health (NIH), Department of Health and Human Services (DHHS); 
National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, (DHHS); NIST, 
DOC; NSF; Nuclear Regulatory Commission; U.S. Geological Survey, Department of the Interior; and U.S. Patent and 
Trademark Office, DOC. 
16 The original six agencies were the NSF, DOD, DOE, NIST, NASA, and NIH. 
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Table 1. NNI Funding, by Agency 
(in millions of current dollars) 
Agency 
FY  
2001 
Actual 
FY  
2002 
Actual 
FY  
2003 
Actual 
FY  
2004 
Actual 
FY  
2005 
Actual 
FY  
2006 
Actual 
FY  
2007 
Actual 
FY  
2008 
Actual 
FY  
2009 
Actual 
FY 
2009 
ARRA 
FY 
2010 
Actual 
FY 
2011 
Actual 
FY 
2012 
Actual 
FY  
2014 
Request 
National Institutes of 
Health (DHHS)a 40 59 78 106 165 192 215 305 343 73 457 409 456 461
National Science 
Foundation 150 204 221 256 335 360 389 409 409 101 429 485 466 431
Department of Energyb 88 89 134 202 208 231 236 245 333 293 374 346 314 370
Department of Defensec 125 224 220 291 352 424 450 460 459 440 425 426 217
National Institute of 
Standards and 
Technology (DOC) 33 77 64 77 79 78 88 86 93 43 115 96 95 102
National Aeronautics and 
Space Administration 22 35 36 47 45 50 20 17 14 20 17 19 18
Environmental 
Protection Agency 5 6 5 5 7 5 8 12 12 18 17 18 17
Other Agencies 1 3 2 5 9 13 19 22 40 62 32 64 87
TOTALd 464 697 760 989 1,200 1,351 1,425 1,554 1,702 511 1913 1,845 1,857 1,767
Source: NNI website. http://www.nano.gov/. Figures for FY2012 and FY2014 from The National Nanotechnology Initiative: Supplement to the President’s FY2014 Budget, 
National Science and Technology Council, Executive Office of the President, May 2013. 
a. According to NIH, the agency has adopted the Research, Condition, and Disease Categorization (RCDC) system to provide more consistent and transparent 
information to the public about NIH research. The shift to the RCDC process of categorization changes the way individual research projects are assigned to 
categories. This change will result in some differences in total dollar amounts between the 2008 reports and those issued in previous years. Any difference, whether an 
increase or decrease in funding levels, does not necessarily reflect a change in the amount of money the NIH received from Congress or a change in the actual content 
of the NIH research portfolio. For more information, please go to: http://report.nih.gov/rcdc/reasons/default.aspx. 
b. According to NSTC, funding levels for DOE include the combined budgets of the Office of Science, the Office of Energy Efficiency and Renewable Energy, the Office of 
Fossil Energy, and the Advanced Research Projects Agency for Energy.  
c. According to NSTC, the Department of Defense budgets for FY2006-FY2011 include congressionally directed funding outside the NNI plan. The extent to which such 
funding is included or not included in reporting of funding in earlier fiscal years is uncertain. 
d. Numbers may not add due to rounding of agency budget figures. 
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Selected Issues 
U.S. Competitiveness 
Nanotechnology is largely still in its infancy. Accordingly, measures such as revenues, market 
share, and global trade statistics—which are often used to assess and track U.S. competitiveness 
in other more mature technologies and industries—are not available for assessing the relative 
U.S. position internationally in nanotechnology. To date, the federal government does not collect 
data on nanotechnology-related revenues, trade, or employment, nor are comparable international 
government data available. Nevertheless, many experts believe that the United States is the global 
leader in nanotechnology. However, some of these experts believe that in contrast to many 
previous emerging technologies—such as semiconductors, satellites, software, and 
biotechnology—the U.S. lead is narrower, and the investment level, scientific and industrial 
infrastructure, technical capabilities, and science and engineering workforces of other nations are 
more substantial than in the past. 
In the absence of comprehensive and reliable economic output data (e.g., revenues, market share, 
trade), indicators such as inputs (e.g., public and private research investments) and non-financial 
outputs (e.g., scientific papers, patents) have been used to gauge a nation’s competitive position in 
emerging technologies. By these measures (discussed below), the United States appears to lead 
the world, generally, in nanotechnology. However, R&D investments, scientific papers, and 
patents may not provide reliable indicators of the United States’ current or future competitive 
position. Scientific and technological leadership may not necessarily result in commercial 
leadership or national competitiveness for a variety of reasons: 
• Basic research in nanotechnology may not translate into viable commercial 
applications. 
• Basic research is generally available to all competitors. 
• U.S.-based companies may conduct production and other work outside of the 
United States. 
• U.S.-educated foreign students may return home to conduct research and create 
new businesses. 
• U.S. companies with leading-edge nanotechnology capabilities and/or intellectual 
property may be acquired by foreign competitors. 
• U.S. policies or other factors may prohibit nanotechnology commercialization, 
make it unaffordable, or make it less attractive than foreign alternatives. 
• Aggregate national data may be misleading as countries may establish global 
leadership in niche areas of nantoechnology. 
With these caveats, the following section reviews input and non-economic output measures as 
indicators of the U.S. competitive position in nanotechnology. 
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Global Funding 
The United States has led, and continues to lead, all nations in known public investments in 
nanotechnology R&D, though the estimated U.S. share of global public investments has fallen as 
other nations have established similar programs and increased funding. In 2011, Lux Research, an 
emerging technologies consulting firm, estimated total (public and private) global 
nanotechnology funding for 2010 to be approximately $17.8 billion with corporate R&D 
accounting for a majority of funding for the first time.17 Cientifica, a privately held 
nanotechnology business analysis and consulting firm, estimated global public investments in 
nanotechnology in 2010 to be approximately $10 billion per year, with cumulative global public 
investments through 2011 reaching approximately $67.5 billion. Cientifica also concluded that 
the United States had fallen behind both Russia and China in nanotechnology R&D funding on a 
purchasing power parity (PPP) basis (which takes into account the price of goods and services in 
each nation), but still leads the world in real dollar terms (adjusted on a currency exchange rate 
basis).18  
Private investments in nanotechnology R&D come from two primary sources, corporations and 
venture capital investors. Lux Research estimated that total global private sector nanotechnology 
funding had risen from $9.2 billion in 2009 to $9.6 billion in 2010, while the venture capital 
component of the investment had fallen from $822 million in 2009 to $646 million in 2010. 
According to the firm, U.S. private sector funding of approximately $3.5 billion led all other 
nations, followed by Japan (almost $3 billion) and Germany (about $1 billion). Lux Research also 
reported that the amount of venture capital funding in Europe was one-fifth that of the North 
American level.19 
According to an analysis by the National Bureau of Economic Research, on a PPP comparison 
basis, the United States led the world in 2006 in corporate R&D investments in nanotechnology 
with an estimated $1.9 billion investment, followed by Japan with $1.7 billion. In total, U.S.- and 
Japan-based companies accounted for nearly three-fourths of global corporate investment in 
nanotechnology R&D in 2006. China ranked fifth in corporate investment, accounting for 
approximately 3% of global private nanotechnology R&D investments.20  
Scientific Papers 
The quantity of peer-reviewed scientific papers is considered by some to be an indicator of a 
nation’s scientific leadership. A study by the National Bureau of Economic Research in 2005 
reported that the U.S. share was a world-leading 24%, but that this represented a decline from 
approximately 40% in the early 1990s, concluding: 
                                                 
17 OECD /NNI International Symposium on Assessing the Economic Impact of Nanotechnology, Background Paper 2: 
Finance and Investor Models in Nanotechnology, Working Party on Nanotechnology, Organization for Economic 
Cooperation and Development, March 16, 2012, p. 4. 
18 Global Funding of Nanotechnologies and Its Impact, Cientifica, July 2011, available at http://cientifica.eu/blog/wp-
content/uploads/downloads/2011/07/Global-Nanotechnology-Funding-Report-2011.pdf. 
19 OECD /NNI International Symposium on Assessing the Economic Impact of Nanotechnology, Background Paper 2: 
Finance and Investor Models in Nanotechnology, Working Party on Nanotechnology, Organization for Economic 
Cooperation and Development, March 16, 2012, p. 4. 
20 Profiting from International Nanotechnology, Lux Research, Inc., December 2006. 
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Taken as a whole these data confirm that the strength and depth of the American science 
base points to the United States being the dominant player in nanotechnology for some time 
to come, while the United States also faces significant and increasing international 
competition.21 
Reflecting the same trend, the number of papers in the Science Citation Index (SCI)22 related to 
nanotechnology discoveries rose from 18,085 in 2000 to approximately 65,000 in 2008, a 
compound annual growth rate (CAGR) of 17.3%. The U.S. share of these papers grew at a 
somewhat slower pace (13.8% CAGR) from 5,342 in 2000 to approximately 15,000 in 2008, 
reducing the total U.S. share from 29.5% in 2000 to approximately 23.1% in 2008.23 
One measure of the importance of a scientific paper is the number of times it is cited in other 
papers. An analysis by Evaluametrics, Ltd. reports that nanotechnology papers attributed to the 
United States are much more frequently cited than those attributed to China, the nations of the 
European Union (EU27), and the rest of the world as a whole. This held true overall and 
separately in each of the four disciplines examined (biology, chemistry, engineering, and physics). 
The U.S. lead was particularly pronounced in biology. China fell below the world average 
number of citations in each discipline, as well as overall. The EU27 performed near the world 
average in engineering and physics, and somewhat higher in chemistry. 
Patents 
Patent counts—assessments of how many patents are issued to individuals or institutions of a 
particular country—are frequently used to assess technological competitiveness. By this measure, 
the U.S. competitive position appears to be strong. A 2007 U.S. Patent and Trademark Office 
analysis of patents in the United States and in other nations stated that U.S.-origin inventors and 
assignees/owners have 
• the most nanotechnology-related U.S. patents by a wide margin; 
• the most nanotechnology-related patent publications globally, but by a narrower 
margin (followed closely by Japan); and 
• the most nanotechnology-related inventions that have patent publications in three 
or more countries, 31.7%, followed by Japan (26.9%), Germany (11.3%), Korea 
(6.6%), and France (3.6%).24 
                                                 
21 Zucker, L.G. and M.R. Darby. “Socio-Economic Impact of Nanoscale Science: Initial Results and Nanobank,” 
National Bureau of Economic Research, March 2005. 
22 The Science Citation Index, a product of Thomson Reuters Corporation, provides bibliographic and citation 
information from more than 3,700 scientific and technical journals published around the world. 
23 Mihail C. Roco, “The long view of nanotechnology development:the National Nanotechnology Initiative at 10 
years,” Journal of Nanoparticle Research, February 2011, p. 429. Growth rates and U.S. percentages of total 
publications calculated by CRS. 
24 Eloshway, Charles. “Nanotechnology Related Issues at the U.S. Patent and Trademark Office,” Workshop on 
Intellectual Property Rights in Nanotechnology: Lessons from Experiences Worldwide, Brussels, Belgium, April 2007. 
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Environmental, Health, and Safety Implications 
Key policy issues associated with U.S. competitiveness in nanotechnology include 
environmental, health, and safety (EHS) concerns; nanomanufacturing; and public understanding 
and attitudes. EHS concerns include both direct consequences for health, safety, and the 
environment, and how uncertainty about EHS implications and potential regulatory responses 
might affect U.S. competitiveness. One such effect might be the discouragement of investment in 
nanotechnology due to the possibility of regulations that might bar products from the market, 
impose high regulatory compliance costs, or result in product liability claims and clean-up costs. 
Some of the unique properties of nanoscale materials—for example, small size, high surface area-
to-volume ratio—have given rise to concerns about their potential implications for health, safety, 
and the environment. While nanoscale particles occur naturally and as incidental by-products of 
other human activities (e.g., soot),25 EHS concerns have been focused primarily on nanoscale 
materials that are intentionally engineered and produced. 
Much of the public dialogue about risks associated with nanotechnology has focused on carbon 
nanotubes (CNTs) and other fullerenes (molecules formed entirely of carbon atoms in the form of 
a hollow sphere, ellipsoid, or tube) since they are currently being manufactured and are among 
the most promising nanomaterials. These concerns have been amplified by some research on the 
effects of CNTs on animals, and on animal and human cells. For example, researchers have 
reported that carbon nanotubes inhaled by mice can cause lung tissue damage;26 that buckyballs 
(spherical fullerines) caused brain damage in fish;27 and that buckyballs can accumulate within 
cells and potentially cause DNA damage.28 On the other hand, some research has found CNTs and 
fullerenes to be non-toxic. In addition, work at Rice University’s Center for Biological and 
Environmental Nanotechnology conducted in 2005 found cell toxicity of CNTs to be low and that 
toxicity can be reduced further through simple chemical changes to the CNT’s surface.29 
Among the potential EHS benefits of nanotechnology are applications that may reduce energy 
consumption, pollution, and greenhouse gas emissions; remediate environmental damage; cure, 
manage, or prevent deadly diseases; and offer new materials that protect against impacts, self-
repair to prevent catastrophic failure, or change in ways that provide protection and medical aid to 
soldiers on the battlefield. 
Potential EHS risks of nanoscale particles in humans and animals depend in part on their potential 
to accumulate, especially in vital organs such as the lungs and brain, that might harm or kill, and 
diffusion in the environment that might harm ecosystems. For example, several products on the 
market today contain nanoscale silver, an effective antibacterial agent. Some scientists have 
                                                 
25 Some naturally occurring nanoparticles cause adverse health effects. Studies on the effects of naturally occurring 
particles are numerous and inform R&D on engineered nanoparticles. 
26 Lam, C.; James, J.T.; McCluskey, R.; and Hunter, R. “Pulmonary toxicity of single-wall carbon nanotubes in mice 7 
and 90 days after intratracheal instillation,” Toxicological Sciences, September 2003. Vol 77. No. 1. pp 126-134. 
27 Oberdörster, Eva. “Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile 
Largemouth Bass,” Environmental Health Perspectives, July 2004. Vol. 112. No. 10. 
28 “Understanding Potential Toxic Effects of Carbon-Based Nanomaterials,” Nanotech News, National Cancer Institute 
Alliance for Nanotechnology in Cancer, July 10, 2006. 
29 “Modifications render carbon nanotubes nontoxic,” press release, Rice University, October 2005. 
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raised concerns that the dispersion of nanoscale silver in the environment could kill microbes that 
are vital to ecosystems. 
Like nanoscale silver, other nanoscale particles might produce both positive and negative effects. 
For example, some nanoscale particles have the potential to penetrate the blood-brain barrier, a 
structure that protects the brain from harmful substances in the blood. Currently, the barrier 
hinders the delivery of therapeutic agents to the brain.30 The characteristics of some nanoscale 
materials may allow pharmaceuticals to be developed to purposefully and beneficially cross the 
blood-brain barrier and deliver medicine directly to the brain to treat, for example, a brain tumor. 
Alternatively, other nanoscale particles might unintentionally pass through this barrier and harm 
humans and animals. 
There is widespread uncertainty about the potential EHS implications of nanotechnology. A 
survey of business leaders in the field of nanotechnology indicated that nearly two-thirds believe 
that “the risks to the public, the workforce, and the environment due to exposure to nano particles 
are ‘not known,’” and 97% believe that it is very or somewhat important for the government to 
address potential health effects and environmental risks that may be associated with 
nanotechnology.31 
Many stakeholders believe that concerns about potential detrimental effects of nanoscale 
materials and products on health, safety, and the environment—both real and perceived—must be 
addressed for a variety of reasons, including: 
• protecting and improving human health, safety, and the environment; 
• enabling accurate and efficient risk assessments, risk management, and cost-
benefit trade-offs; 
• creating a predictable, stable, and efficient regulatory environment that fosters 
investment in nanotechnology-related innovation; 
• ensuring public confidence in the safety of nanotechnology research, 
engineering, manufacturing, and use; 
• preventing the negative consequences of a problem in one application area of 
nanotechnology from harming the use of nanotechnology in other applications 
due to public fears, political interventions, or an overly broad regulatory 
response; and 
• ensuring that society can enjoy the widespread economic and societal benefits 
that nanotechnology may offer. 
Policy issues associated with EHS impacts of nanotechnology include magnitude, timing, foci, 
and management of the federal investment in EHS research; adequacy of the current regulatory 
structures to protect public health and the environment; and cooperation with other nations 
engaged in nanotechnology R&D to ensure all are doing so in a responsible manner. 
                                                 
30 “Blood-Brain Barrier Breached by New Therapeutic Strategy,” press release, National Institutes of Health, June 
2007. 
31 “Survey of U.S. Nanotechnology Executives,” Small Times Magazine and the Center for Economic and Civic 
Opinion at the University of Massachusetts-Lowell, Fall 2006. 
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Nanomanufacturing 
Securing the economic benefits and societal promise of nanotechnology requires the ability to 
translate knowledge of nanoscience into market-ready nanotechnology products. 
Nanomanufacturing is the bridge connecting nanoscience and nanotechnology products. Although 
some nanotechnology products have already entered the market, these materials and devices have 
tended to require only incremental changes in manufacturing processes. Generally, they are 
produced in a laboratory environment in limited quantities with a high degree of labor intensity, 
high variability, and high costs. To make their way into safe, reliable, effective, and affordable 
commercial-scale production in a factory environment may require the development of new and 
unique technologies, tools, instruments, measurement science, and standards for 
nanomanufacturing. 
Public Attitudes and Understanding 
What the American people know about nanotechnology and the attitudes that they have toward it 
may affect the environment for research and development (especially support for public R&D 
funding), regulation, market acceptance of products incorporating nanotechnology, and, perhaps, 
the ability of nanotechnology to weather a negative event such as an accident or spill. 
In 2007, the Woodrow Wilson International Center for Scholars’ Project on Emerging 
Nanotechnologies (PEN) reported results of a nationwide poll of adults that found more than 42% 
had “heard nothing at all” about nanotechnology, while only 6% said they had “heard a lot.” In 
addition, more than half of those surveyed felt they could not assess the relative value of 
nanotechnology’s risks and benefits. Among those most likely to believe that benefits outweigh 
risks were those earning more than $75,000 per year, men, people who had previously heard 
“some” or “a lot” about nanotechnology, and those between the ages of 35 and 64. Alternatively, 
among those most likely to believe that the risks of nanotechnology outweigh benefits include 
people earning $30,000 or less; those with a high school diploma or less; women; racial and 
ethnic minorities; and those between the ages of 18 and 34 or over age 65.32 
The PEN survey found a strong positive correlation between familiarity with and awareness of 
nanotechnology and perceptions that benefits will outweigh risks. However, the survey data also 
indicate that communicating with the public about nanotechnology in the absence of clear, 
definitive answers to EHS questions could create a higher level of uncertainty, discomfort, and 
opposition. 
Congress expressed its belief in the importance of public engagement in the 21st Century 
Nanotechnology Research and Development Act of 2003 (15 U.S.C. §§7501 et seq.). The act 
calls for public input and outreach to be integrated into the NNI’s efforts. The NNI has sought to 
foster public understanding through a variety of mechanisms, including written products, 
speaking engagements, a web-based information portal (nano.gov), informal education, and 
efforts to establish dialogues with stakeholders and the general public. The NSET subcommittee 
has also established a Nanotechnology Public Engagement and Communications working group 
to develop approaches by which the NNI can communicate more effectively with the public. 
                                                 
32 “Awareness of and Attitudes Toward Nanotechnology and Federal Regulatory Agencies: A Report of Findings,” 
survey by Peter D. Hart Research Associates, Inc., for the Project on Emerging Nanotechnologies, September 2007. 
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